The online conversations about breast cancer drug Kadcyla before it was approved by NICE.
Greater patient centricity, collaboration and new technology are re-shaping clinical trials.
The optimal cancer care pathway for this complex disease outside the hospital.
Complex and evolving cancer treatment pathways require comprehensive and tailored support programmes.
The benefits and pitfalls of patient-centric and patient-led trials.
Health literacy study suggests more than 90% of adults need health information to be written for a reading age of 9-11 years.
Dynamic consent models for patients can develop ongoing partnership between participants and researchers.
A practical guide to planning and running an effective patient support programme.
Benefitting from insights from focus groups with rare disease patients.
